Robertet Group account plan
Natural products manufacturing
At a glance
Robertet is a Grasse-based, family-controlled maker of natural raw materials, fragrances, flavors and actives, with €844 million revenue in 2025.
Robertet SA, founded in Grasse in 1850 and controlled by the Maubert family, sources and transforms plant-based raw materials into natural extracts used to create flavors, fragrances and active ingredients for other companies' products. Its Seed to Scent™ model runs from grower partnerships through extraction to creation, with more than 1,600 natural raw materials from 60 countries, 30 industrial sites and 17 creative and research centers. In 2025 revenue was €844 million (+4.5%, 7.6% organic), EBITDA margin 20.6% and attributable net income €103,427 thousand, with 2,750 employees at December 31, 2025. Philippe Maubert chairs the Board and Jérôme Bruhat has been CEO since July 1, 2022; Maubert SA holds 34.7% of the capital and 54.5% of voting rights.
Business units
Fragrance
37% of 2025 revenue (€311.4 million)Fragrances for eau de toilette, personal hygiene and cleaning brands, from luxury houses to fast-growing new brands. Growth was 2.1% like for like in 2025, then +13% organic in H1 2026 on fine fragrance, niche brands and body care. Julien Maubert has led the Division since January 1, 2026.
Flavor
34% of 2025 revenue (€290.3 million)Flavors for beverages, dairy, confectionery, ready meals and pharmaceuticals. It grew 10.4% at constant exchange rates and scope in 2025 with new creative centers in Asia and Mexico, but fell 2% organic in H1 2026 in a cautious market, particularly in the United States.
Raw Materials
26% of 2025 revenue (€219.3 million)Natural ingredients for flavor and fragrance customers and peers, from plant sourcing to extraction and purification, led by materials such as New Caledonian sandalwood. Growth was 14% at constant exchange rates in 2025, then -6% organic in H1 2026 against a high comparison base. Patrick Rogier took over the Division in 2025.
Health & Beauty
3% of 2025 revenue (€22.9 million)Active ingredients from natural extracts for health and beauty products, such as LIPOWHEAT™ and Damasty™. Revenue grew 10.8% in 2025 and 11.3% in H1 2026; the Division is meant to reach 6% of revenue by 2030 and is led by Olivier Maubert.
Strategic priorities
- Seed to Success 2030
- The plan targets revenue of €1.1 to 1.2 billion by 2030 (5% to 7% average annual growth), an EBITDA margin above 20% and free cash flow before acquisitions of €105 to 115 million.
- Acceleration in high-growth countries
- Ten key countries in South-East Asia, the Middle East and South America should represent more than half of group growth to 2030, backed by a regional organization in seven areas.
- Targeted acquisitions
- External growth should account for a quarter to a third of growth, with acquisitions representing €50 to 80 million of revenue by 2030.
- Augmented naturality and innovation
- Robertet invests in plant biotechnology (Aethera Biotech), the NaturIA AI assistant for perfumers and flavorists, and about 20 start-ups at Villa Blu in Grasse.
- Certified and sustainable sourcing
- 2030 CSR targets include 100% of strategic natural raw materials certified or audited, and Scope 1 and 2 emissions down 54.6% by 2033 against 2023 on an SBTi-validated pathway.
Latest results
In the first half of 2026 revenue was €444.3 million against €446.3 million (-0.5%): organic growth of +2.8% was offset by a -3.0% currency effect. Fragrances grew 13% organic while Flavors fell 2% and Raw Materials 6%; South America rose 21% and Asia 12%, while Europe MEA and North America each fell 1%. Recurring EBITDA was €93.6 million (21.1%) against €100.2 million (22.5%), mainly because of ongoing investments, and attributable net income was €54.2 million. Robertet targets organic revenue growth of between 3% and 5% for full-year 2026 and reaffirms its 2030 goals.
Investments and deals
- Industrial capacity
- Capex was €43.8 million in 2025, including a new regional hub at Karawang, Indonesia, a spray-drying unit at Sonarome in Bangalore, Grasse modernization and a Mexican plant doubling in size; projects for Taif roses (Saudi Arabia) and in Yunnan follow in 2026.
- Aethera Biotech
- A 25% stake bought in March 2026 for €1.1 million, with a path to 50% after December 31, 2028, to enter plant biotechnologies for cosmetic actives.
- Nhat Tan stake
- On September 16, 2026 Robertet SA acquired 10% of Nhat Tan, its long-standing Vietnamese partner in natural ingredients.
- UNIFY information-systems program
- A Group-wide program to harmonize data governance and practices is being rolled out with cybersecurity work, as the medium-term IT plan moves to SaaS and outsourced hosting.
- Financing
- An €80 million revolving credit facility was signed on June 9, 2026 and first drawn €50 million on July 3, 2026.
Challenges and risks
- Cyberattacks and IT obsolescence
- Cyberattacks are the top-rated risk in the 2025 report, and IT obsolescence is rated +++.
- Raw-material sourcing
- Climate events, embargoes and competition could cause scarcity of natural raw materials; 58% of strategic supply chains are certified.
- US tariffs and cautious customers
- US customs duties forced price negotiations, and H1 2026 saw greater caution among customers in Europe and North America.
- Currency headwinds
- The currency effect cut €28 million (3.5%) of 2025 revenue and 3.0% in H1 2026.
- Talent and key knowledge
- Loss of key knowledge holders and recruiting and retaining talent are both rated +++ risks.
What leadership says
“Now more than ever, we are reaffirming our core principles of independence, agility and growth.”
“top priority is to prepare for the future, invest and accelerate our growth”
“We are first and foremost, and at heart, an industrial company.”
“We will invest and work together.”
Where a supplier can help
- IT modernization and cybersecurity
- The UNIFY program, the move to SaaS and outsourced hosting and cyberattacks as the top risk create openings for ERP, data governance and security suppliers.
- Industrial automation and equipment
- New and expanded plants in Indonesia, India, Mexico, Saudi Arabia and Yunnan, plus more automation of industrial processes, suit extraction, drying and automation equipment vendors.
- Supply-chain traceability
- Sourcing risk and the target of 100% certified or audited strategic raw materials point to traceability, certification and supplier-audit services.
- Market entry in growth countries
- The push into ten high-growth countries and new subsidiaries supports local distribution, recruiting and regulatory partners.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Robertet Group?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- 2025 Annual Financial Report
- Robertet is a family-controlled Grasse group (founded 1850) that sources and transforms plant-based raw materials into natural extracts used to create fragrances, flavors and active ingredients; it calls itself the world leader in natural raw materials, with 1,600+ natural raw materials sourced from 60 countries, 30 industrial sites, 17 creative centers and more than 2,700 employees.
- FY2025 revenue was €843.9 million, up 4.5% reported, 8% at constant exchange rates and 7.6% organic; a very negative exchange-rate effect of €28 million cut growth by 3.5%.
- EBITDA rose 10.9% to €174 million (20.6% of revenue); attributable net income passed €100 million for the first time at €103.4 million (+14.8%, 12.3% of revenue); proposed dividend €12.00 per share (from €10.00).
- Four Divisions: Fragrance 37% of revenue (+2.1% at constant rates, US customers' inventory reductions), Flavor 34% (+10.4%), Raw Materials 26% (+14% at constant rates; the introduction gives 25% and +12.4% like for like) and Health & Beauty 3% (+10.8%).
- Growth outside Europe and the United States reached 20%; Latin America grew 32.8% organically, North Asia 14%, South-East Asia 12.8%, Europe 9.6%, North America only 2.5%.
- Investment: €44 million of capex in 2025 (€38 million in 2024): new Karawang plant in Indonesia, a spray-drying unit at Sonarome in Bangalore, Grasse upgrades, new creative centers in Shanghai, New York, Mexico, Dubai and Singapore; free cash flow fell from €74 million to €45 million.
- Strategy: the "Seed to Success 2030" plan presented at the first Capital Markets Day (May 2025), where the 2030 revenue target was raised; priorities are international expansion, innovation (NaturIA AI assistant, Villa Blu start-up hub, Aethera Biotech stake in early 2026) and sustainable development (67+ certified supply chains, SBTi pathway to 2033 validated, EcoVadis Platinum).
- Ownership: Maubert SA and the family hold 40.2% of the capital and 62.3% of voting rights; Fonds Stratégique de Participations and Peugeot Invest Assets each hold 7.6% of the capital and joined the Board.
- Top-rated risks: cyberattacks (the only ++++ risk), raw-material sourcing under climate and geopolitical stress, IT obsolescence, change management with globalization, loss of key knowledge holders and talent retention, CSR reputational exposure through third parties; US customs duties forced price negotiations.
- Leadership: Philippe Maubert chairs the Board, Jérôme Bruhat has been CEO since July 1, 2022; Julien Maubert took over the Fragrance Division on January 1, 2026 from Christophe Maubert (Deputy Chairman), Patrick Rogier now heads Raw Materials, Olga Renda-Blanche became the first Chief Human Resources Officer.
- 2026 Interim Financial Report (condensed interim consolidated financial statements, six months ended June 30, 2026)
- H1 2026 revenue was €444.3 million (€446.3 million in H1 2025, -0.5% reported): organic growth +2.8%, currency effect -3.0% (strong euro), scope -0.3%.
- Recurring EBITDA €93.6 million, 21.1% of revenue (€100.2 million, 22.5% in H1 2025); operating income €75.4 million (17.0%); attributable net income €54.2 million (12.2%), EPS €25.81.
- The fall in EBITDA is put down to investment for future growth: manufacturing capacity, larger scientific and sales teams, information systems (UNIFY program).
- Fragrances (40% of revenue) grew 13% organically on niche fine-fragrance brands and new body-care players, especially in the Middle East and Latin America; Flavors (34%) -2% in a cautious US market; Raw Materials (24%) -6% against a high base; Health & Beauty (3%) +11.3%.
- By region: Europe MEA (43%) and North America (31%) both -1% organic; South America (10%) +21% led by Brazil with a new São Paulo creation center; Asia (16%) +12% with the Indonesian plant ramp-up and Flavors in India.
- Outlook: organic revenue growth of 3% to 5% for full-year 2026, 2030 goals reaffirmed, investment strategy maintained.
- Corporate: 25% of Aethera Biotech bought for €1.1 million (March 2026) with options toward 50%; an €80 million five-year revolving credit facility signed June 9, 2026, first drawn €50 million on July 3; 10% of Vietnamese partner Nhat Tan acquired September 16, 2026.
- Risks flagged: Middle East conflict (transport, energy and supply costs), US trade policy; Robertet is seeking refunds of IEEPA tariffs after the February 2026 Supreme Court ruling.
- Robertet, le seigneur de Grasse (Le Point)
- Le Point profile built on interviews with CEO Jérôme Bruhat and Chairman Philippe Maubert at Robertet's Grasse headquarters.
- Bruhat targets €1 billion of revenue in 2030 and says that at the current pace Robertet will do better; growth is to come from high-potential markets where it is under-represented (translated).
- Sales split about a third Europe, a third United States, a third rest of the world; the Middle East is only 5% of sales but growing fast; Asia (China) and Brazil are priorities.
- Bruhat wants Robertet "even more present" with the challenger fragrance brands of tomorrow (Sol de Janeiro, To Summer, Wepink, 100 Bon) while keeping its historic luxury customers (translated).
- Robertet does not try to create synthetic molecules like Firmenich, IFF or Givaudan; it buys them in India or China and doubles down on natural materials, with a catalog of 1,615 references from about sixty countries.
- Maubert: "We are the kings of the noble natural product" (translated); independence was "not negotiable" (translated) when Firmenich built a stake of up to 30%; the exit was settled at end-2025 with FSP and Peugeot's family holding coming in (14.2% of the capital between them).
- The Maubert family holds nearly 40% of the shares and 60% of voting rights; the fifth generation runs perfumery (Julien Maubert), strategy and new markets (Arthur Le Tourneur d'Ison) and the UK subsidiary (Jean-Baptiste Maubert); Bruhat says decision circuits are fast.
- Robertet lance son premier Capital Markets Day (WanSquare interview)
- WanSquare interview with CEO Jérôme Bruhat on the day of Robertet's first Capital Markets Day (Grasse, May 22, 2025), presenting the "Seed to Success" 2030 roadmap.
- 2030 targets: revenue of €1.1-1.2 billion (5-7% average annual growth), EBITDA margin above 20%, return on capital employed stable around 16%, free cash flow before acquisitions of €105-115 million.
- Acquisitions should provide a quarter to a third of growth, €50-80 million of revenue by 2030; Bruhat says the strategy "does not rest mainly on acquisitions" but they help when complementary (translated), citing Sonarome in India.
- Health & Beauty should double its weight to 6% of revenue by 2030; Fragrances stays dynamic and Flavors is to accelerate in emerging markets.
- Ten priority countries in South-East Asia, the Middle East and South America, growing twice as fast as the world flavors and fragrances market, should provide more than half of group growth; a seven-region, more autonomous organization.
- Industrial push: 80% of revenue is outside France; a factory is being built in Indonesia and the Mexican one doubled; Bruhat: "we are first and foremost, at heart, an industrial company" (translated).
- Governance: Peugeot Invest and FSP joined the capital; the Executive Committee became a 14-member global committee, five of whom joined in the last three years.
- Robertet déroule sa stratégie d'innovation en investissant dans Aethera Biotech (WanSquare interview)
- WanSquare interview (March 6, 2026) with Olivier Maubert, Robertet's Chief Innovation Officer and head of the Health & Beauty Division, on the group's first biotech investment.
- Robertet invests in Aethera Biotech through a joint venture with its parent, the Italian family group Cereal Docks; the investment comes in two phases over three years, ending with the company held in equal shares, with no takeover planned.
- Aethera Biotech (northern Italy, created 2016) has 25 staff from R&D to industrialization and eight patents on cell-multiplication production of cosmetic actives; its revenue is not disclosed and the goal is to multiply it by ten in five years.
- Robertet brings market access: its established cosmetics customers include L'Oréal, Shiseido and Clarins, and it will distribute Aethera's portfolio.
- Rationale: Robertet's model rests on natural biomass whose availability is threatened by climate change and geopolitics, so alternatives fit its "augmented naturality" strategy (translated).
- Health & Beauty is strong in cosmetic nutrition (supplements) but weaker in topical actives with proven benefits; the targeted market is "several tens of millions of euros" (translated).
- CEO Jérôme Bruhat: biotechnologies "will play a growing role" in sustainable high value-added solutions (translated).
Questions about Robertet Group
What does Robertet do?
Robertet sources and transforms plant-based raw materials into natural extracts, then creates fragrances, flavors and active ingredients that customers put into perfumes, foods, beverages, cosmetics and household products.
What was Robertet's revenue in 2025?
Revenue was €844 million in 2025, up 4.5% (7.6% organic), with an EBITDA margin of 20.6%.
How many employees does Robertet have?
2,750 employees at December 31, 2025, against 2,587 a year earlier.
Who leads Robertet?
Philippe Maubert is Chairman and Jérôme Bruhat, the first non-Maubert at the head of the company, has been CEO since July 1, 2022.
What is Robertet's strategy?
Seed to Success 2030 targets €1.1 to 1.2 billion of revenue by 2030 through international expansion, innovation in naturals and biotechnology, sustainable sourcing and complementary acquisitions.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)